A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q1 FY2023, filed Feb 9, 2023. Each column of the statement tables below links to the filing it was taken from.
This page shows RETRIEVE MEDICAL HLDG INC (RMHI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
RETRIEVE MEDICAL HLDG INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
RETRIEVE MEDICAL HLDG INC passes 2 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass.
RETRIEVE MEDICAL HLDG INC reported a net loss of $165K while operations used $69K of cash. With neither figure positive, the ratio between the two carries no quality signal.
RETRIEVE MEDICAL HLDG INC reported an operating loss of $163K against $32K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
RETRIEVE MEDICAL HLDG INC reported -$112K in net income in Q1 2023. This represents a decrease of 89.1% from the same quarter a year earlier.
Not reported for Q1 2023.
Not reported for Q1 2023.
Not reported for Q1 2023.
Cash & Balance Sheet
RETRIEVE MEDICAL HLDG INC held $97K in cash as of Q1 2023; long-term debt is not reported for that period.
Not reported for Q1 2023.
Not reported for Q1 2023.
Margins & Returns
None of these metrics is reported for Q1 2023.
Capital Allocation
None of these metrics is reported for Q1 2023.
RMHI Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2310-Q | Q4'2210-Q | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q | Q4'2110-K | Q3'2110-Q | Q2'2110-Q |
|---|---|---|---|---|---|---|---|---|
| SG&A Expenses | $110K+112.1% | N/A | $12K-28.2% | $47K | $52K | N/A | $17K+1299.1% | N/A |
| Operating Income | -$110K-112.1% | N/A | -$12K+28.2% | -$47K | -$52K | N/A | -$17K-1299.1% | N/A |
| Interest Expense | $2K-79.3% | N/A | $8K+236.8% | $8K | $9K | N/A | $2K | N/A |
| Net Income | -$112K-89.1% | N/A | $9K+146.0% | -$55K | -$59K | N/A | -$19K | N/A |
| EPS (Basic) | N/A | N/A | N/A | N/A | N/A | N/A | $0.00 | N/A |
| EPS (Diluted) | N/A | N/A | $0.00 | N/A | N/A | N/A | N/A | N/A |
| Diluted Shares (Avg) | N/A | N/A | 82M | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, EBITDA, Income Tax.
RMHI Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2310-Q | Q4'2210-Q | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q | Q4'2110-K | Q3'2110-Q | Q2'2110-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $102K-46.9% | $130K-50.1% | $134K+213.4% | $180K+51683.3% | $193K+50972.5% | $261K+63907.8% | $43K+9668.9% | $348-25.6% |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $348-25.6% |
| Cash & Equivalents | $97K-48.4% | $128K-51.1% | $131K+207.0% | $176K+50498.0% | $188K+49517.5% | $261K | $43K | $348 |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $706K+22.0% | $622K+5.8% | $565K+56.1% | $620K-88.0% | $579K+124.4% | $587K+134.5% | $362K+47.1% | $5.2M+2025.3% |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $301K+23.9% |
| Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $4.9M |
| Total Equity | -$603K-56.5% | -$491K-50.6% | -$431K-35.0% | -$440K+91.5% | -$386K-49.8% | -$326K-30.4% | -$319K-30.0% | -$5.2M-2029.3% |
| Retained Earnings | -$5.5M-4.2% | -$5.4M-3.2% | -$5.3M-2.2% | -$5.3M-2.7% | -$5.2M-2.5% | -$5.2M-1.5% | -$5.2M-1.4% | -$5.2M-1.1% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
RMHI Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.
RMHI Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$491K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| RETRIEVE MEDICAL HLDG INC RMHI | FY2022 | N/A | -$165K | N/A | $29.2M | — |
| RENALYTIX PLC SP/ADR RNLXY | FY2024 | $2.3M | -$33.5M | N/A | $50.1M | — |
| REVIUM RECOVERY INC RVRC | FY2025 | N/A | -$13.4M | N/A | $86.8M | — |
Where RETRIEVE MEDICAL HLDG INC Ranks
Frequently Asked Questions
Is RETRIEVE MEDICAL HLDG INC profitable?
No, RETRIEVE MEDICAL HLDG INC (RMHI) reported a net income of -$165K in fiscal year 2022.
What is RETRIEVE MEDICAL HLDG INC's operating cash flow?
RETRIEVE MEDICAL HLDG INC (RMHI) recorded an outflow of $69K in operating cash flow during fiscal year 2022, representing cash used by core business activities.
What are RETRIEVE MEDICAL HLDG INC's total assets?
RETRIEVE MEDICAL HLDG INC (RMHI) had $130K in total assets as of fiscal year 2022, including both current and long-term assets.
What is RETRIEVE MEDICAL HLDG INC's return on assets (ROA)?
RETRIEVE MEDICAL HLDG INC (RMHI) had a return on assets of -126.6% for fiscal year 2022, measuring how efficiently the company uses its assets to generate profit.
What is RETRIEVE MEDICAL HLDG INC's P/E ratio?
RETRIEVE MEDICAL HLDG INC (RMHI) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2022). The market capitalization is $29.2M as of Sep 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is RETRIEVE MEDICAL HLDG INC's price-to-sales ratio?
RETRIEVE MEDICAL HLDG INC (RMHI) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $29.2M as of Sep 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does RETRIEVE MEDICAL HLDG INC's liquidity compare with its operating cash outflow?
At the end of fiscal year 2022, RETRIEVE MEDICAL HLDG INC (RMHI) held $128K in cash, cash equivalents and investments, and reported an operating cash outflow of $69K over that year. Dividing the one by the other, the reported balance equals about 22 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is RETRIEVE MEDICAL HLDG INC's debt-to-equity ratio negative or not reported?
RETRIEVE MEDICAL HLDG INC (RMHI) has negative shareholder equity of -$491K as of fiscal year 2022, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is RETRIEVE MEDICAL HLDG INC's Piotroski F-Score?
RETRIEVE MEDICAL HLDG INC (RMHI) has a Piotroski F-Score of 2 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are RETRIEVE MEDICAL HLDG INC's earnings high quality?
RETRIEVE MEDICAL HLDG INC (RMHI) reported a net loss of $165K while operations used $69K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can RETRIEVE MEDICAL HLDG INC cover its interest payments?
RETRIEVE MEDICAL HLDG INC (RMHI) reported an operating loss of $163K against $32K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.